healthcare
FinanceHospital Massacre Caps Long Series of Attacks on Healthcare in War-Torn Sudan
Analysis-Undeterred by Novo Nordisk Failure, Scientists Consider GLP-1s as Alzheimer's Prevention
Novo Nordisk 'lottery Ticket' Alzheimer's Trials Fail to Deliver Reward
Novo Nordisk Alzheimer's Drug Trials Fail in Blow to Weight-Loss Giant
Lilly Becomes First Drugmaker to Hit $1 Trillion Valuation on Weight-Loss Demand
Date: November 21, 2025
By Mrinalika Roy (Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a...
Novo, Lilly Collaborate With Waltz Health to Sell Weight-Loss Drugs Directly to Employers
Date: November 21, 2025
(Reuters) -Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo Nordisk and Eli Lilly directly to employers, bypassing traditional...
UK's Drug-Cost Watchdog Recommends Alnylam's Heart Disease Drug
Date: November 21, 2025
(Reuters) -The UK's drug cost-effectiveness watchdog has recommended Alnylam Pharmaceuticals' heart disease drug, ensuring access for patients through the government health system in England and Wales...
UK Government Asks Competition Watchdog to Probe Private Dentistry
Date: November 18, 2025
LONDON (Reuters) -The UK government on Tuesday urged the competition watchdog to launch an investigation into private dentistry costs and practices amid concerns that patients may be paying more than...
Novo Nordisk Rolls Out $349 Wegovy Cash Price Ahead of Plan
Date: November 17, 2025
By Patrick Wingrove (Reuters) -Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump...
Novo Nordisk Cuts Wegovy Price as CEO Pledges to Go 'all In' on Weight Loss Pill
Date: November 17, 2025
COPENHAGEN (Reuters) -Novo Nordisk has more than enough of its Wegovy weight-loss pills to support an aggressive product launch, CEO Mike Doustdar said on Monday, looking to avoid a repeat of the...